In the treatment of intoxication must create nandrolone side effects excess carbon in the stomach (before it wash) and gut (stomach after washing). Reducing the carbon concentration holly holm record in the medium promotes desorption related substance and its absorption (repeated gastric lavage and charcoal appointment is recommended to prevent the resorption of the released substances). The presence of food in the gastrointestinal mass -kishechnom tract requires the introduction of activated carbon in high doses because the contents of the digestive tract is absorbed carbon and its activity is reduced. If the poisoning is caused by substances involved in the enterohepatic circulation (cardiac glycosides, indomethacin, morphine and others. Opioids), you must use coal for a few days. When using the drug more than 10-14 days is necessary prophylactic vitamin and calcium supplements (only under medical supervision).
Hypercalcemia may develop both spontaneously and as a result of androgen therapy in women with disseminated breast carcinoma. If it develops while on this agent, the drug should be discontinued. Caution is required in administering these agents to patients with cardiac, renal or hepatic disease. Cholestatic jaundice is associated with therapeutic use of anabolic and androgenic steroids. Edema may occur occasionally with or without congestive heart failure. Concomitant administration of adrenal steroids or ACTH may add to the edema. In children, anabolic steroid treatment may accelerate bone maturation without producing compensatory gain in linear growth. This adverse effect may result in compromised adult stature. The younger the child the greater the risk of compromising final mature height. The effect on bone maturation should be monitored by assessing bone age of the wrist and hand every six months. This drug has not been shown to be safe and effective for the enhancement of athletic performance. Because of the potential risk of serious adverse health effects, this drug should not be used for such purpose.
Spironolactone is frequently used as a component of hormone replacement therapy in transgender women , especially in the United States (where cyproterone acetate is not available), usually in addition to an estrogen .    Spironolactone significantly depresses plasma testosterone levels, reducing them to female/castrate levels at sufficient doses and in combination with estrogen. The clinical response consists of, among other effects, decreased male pattern body hair , the induction of breast development , feminization in general, and lack of spontaneous erections .